Skip to main content
Log in

Cost effectiveness of targeted testing for latent TB in USA

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2018 US dollars

Reference

  • Jo Y, et al. Model-Based Cost-Effectiveness of State-level Latent Tuberculosis Interventions in California, Florida, New York and Texas. Clinical Infectious Diseases : 25 Jun 2020. Available from: URL: http://doi.org/10.1093/cid/ciaa857

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cost effectiveness of targeted testing for latent TB in USA. PharmacoEcon Outcomes News 857, 7 (2020). https://doi.org/10.1007/s40274-020-6944-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6944-9

Navigation